Olimab 60 mg Injection contains denosumab, a monoclonal antibody used to treat osteoporosis and reduce fracture risk in postmenopausal women and men with low bone density. It also helps prevent bone loss in patients undergoing certain cancer treatments by blocking RANKL, a protein involved in bone breakdown, thereby improving bone strength and density.
Olimab is administered as a subcutaneous injection once every six months by a healthcare professional, along with recommended calcium and vitamin D supplements. Common side effects may include back, joint, or muscle pain and urinary infections, while rare but serious effects include low calcium levels, jaw bone problems, or unusual thigh fractures. Inform your doctor about kidney issues, low calcium, or dental problems, and attend regular check-ups for safe and effective treatment.
Olimab 60 mg Injection contains denosumab, a monoclonal antibody that targets and blocks RANKL, a protein responsible for bone breakdown. By stopping RANKL from activating osteoclasts the cells that break down bone it helps slow bone loss, increase bone density, and strengthen bones. This reduces the risk of fractures in people with osteoporosis and in patients undergoing cancer treatments that may weaken bones.
Side Effects of Olimab 60 mg Injection
Like all medications, Olimab 60 mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
It is important to inform your doctor about any unusual symptoms and to maintain adequate calcium and vitamin D intake during treatment.
Common Side Effects (Usually mild and temporary):
Olimab 60 mg Injection is given as a single subcutaneous injection once every six months by a healthcare professional. Calcium and vitamin D supplements are usually recommended during treatment to support bone health and maintain normal calcium levels.
Avoid using Olimab 60mg Injection while breastfeeding unless advised by your doctor.
It is advisable to limit alcohol intake, as excessive consumption can weaken bones and increase the risk of side effects.
Use Olimab 60 mg Injection with caution if you have existing lung problems, and immediately inform your doctor if you experience cough, shortness of breath, or chest discomfort during treatment.
Olimab 60mg Injection is unlikely to affect your ability to drive or use machines. However, if you feel dizzy or tired, avoid such activities.
Olimab 60mg Injection is not recommended for use during pregnancy. Inform your doctor if you are pregnant or planning to conceive.
Olimab is used to treat osteoporosis and bone loss in postmenopausal women and men at high risk of fractures. It is also used in patients receiving hormone therapy for prostate or breast cancer.
Olimab is given as a subcutaneous injection (under the skin) once every six months by a healthcare professional.
If you miss a dose, get it as soon as possible. Future doses should be scheduled every six months from the last injection date.
Yes. Common side effects include back pain, joint pain, high cholesterol, and urinary tract infections. Serious side effects can include low blood calcium levels, infections, and rare jaw or thigh bone problems.
Use with caution in people with kidney issues, as the risk of low calcium levels increases. Your doctor may recommend calcium and vitamin D supplements and regular monitoring.
No, Olimab is not recommended during pregnancy or breastfeeding. Inform your doctor if you are pregnant or planning to become pregnant.
| Active ingredient | Denosumab |
| Pharmacologic class | Monoclonal antibody |
| Medication category | Antiresorptive agent |
| Dosage forms | Injection |
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
